News

ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc., a developer of enhanced ultrasound technologies, has contracted with CIMTEC, a leading contract research...

A new study published by CIMTEC client Proteocyte provides further data showing Straticyte offers better predictive insight over...

TORONTO, ON − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the “Company” or “3DS”), is pleased to announce that the clinical trial...

Brings deep experience in medtech commercialization LONDON (August 8, 2017) – The Centre for Imaging Technology Commercialization (CIMTEC)...

TORONTO--(BUSINESS WIRE)--KalGene Pharmaceuticals Inc., in collaboration with the National Research Council of Canada (NRC), CIMTEC and the...

3D Signatures (TSX Venture: DXD.V; OTCQB: TDSGF; Frankfurt: 3DO) is a medical imaging company that is developing diagnostic tools based on...

CIMTEC

CIMTEC spin-off NeoVision was founded to commercialize the neonatal brain imaging technology derived from Dr. Aaron Fenster's research at...

OBI logo

UPDATE AS OF FRIDAY MARCH 17TH 4:00PM   IMPORTANT - DEADLINE EXTENDED TO TUESDAY MARCH 21ST!   2017 OBI ONtrepreneurs Program Application...

Ontario’s wealth of cancer research expertise is not limited to one city or region. Innovations from researchers and clinician-scientists...

TechAlliance

FedDev Ontario Invests $1.32 Million to Support 30 Companies and Create Jobs News Release From Federal Economic Development Agency for...

Pages